Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710203 · ClinicalTrials.gov registry record · NA
Dermatosis Papulosa Nigra
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00710203 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 10 participants.
The verdict
NCT00710203, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face. The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions off) and electrodesiccation (burning the lesions off).
Interventions
- OTHER No treatment
- DEVICE Pulsed dye laser
- PROCEDURE Curettage
- PROCEDURE Electrodesiccation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00710203
The ClinicalTrials.gov registry entry for NCT00710203 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which No treatment is the first listed.
NCT00710203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00710203 about?
NCT00710203 is a clinical study titled "Dermatosis Papulosa Nigra". DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face. The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettag...
What is the current status of trial NCT00710203?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2008-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00710203?
The interventions under investigation include: No treatment (OTHER), Pulsed dye laser (DEVICE), Curettage (PROCEDURE), Electrodesiccation (PROCEDURE).
Who is sponsoring clinical trial NCT00710203?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.